Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest update is out from dorsaVi Limited ( (AU:DVL) ).
dorsaVi Limited has renewed its research contract with Georgia Southern University, funded by the U.S. Department of Defense, to deploy its wearable sensors in field-based military training to address stress fractures among trainees. The study extends earlier lab-based work by delivering real-time gait and running biofeedback in uncontrolled load-bearing environments, aiming to lower tibial shock and reduce injuries that can sideline personnel for up to 18 weeks.
dorsaVi’s technology captures detailed running metrics such as initial peak acceleration, ground reaction force, contact time, cadence and foot strike patterns, supported by two granted U.S. patents that protect its gait-modification methodology. The contract reinforces the company’s credibility in mission-critical defence applications and underpins its strategy to expand into exoskeleton and robotics systems without requiring new foundational R&D, leveraging its existing sensor and neuromorphic semiconductor capabilities.
More about dorsaVi Limited
dorsaVi Limited is an Australian technology company that develops wearable biomechanical sensor platforms used to capture and analyse human movement in real time. Its systems focus on gait, running mechanics and related metrics, serving high-stakes markets such as defence, elite sport, and advanced robotics where injury reduction and performance optimisation are critical.
Average Trading Volume: 936,553
Technical Sentiment Signal: Buy
Current Market Cap: A$48.4M
Learn more about DVL stock on TipRanks’ Stock Analysis page.